Keyphrases
Tumor
64%
Childhood Cancer Survivors
57%
Pediatric
50%
Dutch
45%
Acute Lymphoblastic Leukemia
43%
Childhood Cancer
42%
Neuroblastoma
39%
Organoids
36%
Survivors
35%
Wilms Tumor
30%
Children with Cancer
30%
Pediatric Patients
29%
Chemotherapy
29%
Pediatric Oncology
29%
Overall Survival
27%
Confidence Interval
25%
Acute Myeloid Leukemia
24%
Radiotherapy
23%
Netherlands
23%
Leukemia
23%
Risk Factors
21%
Late Effects
20%
Older Adults
20%
Rhabdomyosarcoma
20%
Event-free Survival
20%
Pediatric Leukemia
19%
High Risk
19%
Working Diagnosis
18%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
16%
Pediatric Acute Lymphoblastic Leukemia
15%
Pediatric Soft Tissue Sarcomas
15%
Meta-analysis
15%
Pharmacokinetics
15%
Cancer Treatment
14%
Health-related Quality of Life
14%
Renal Tumor
14%
In Cancer
14%
T Cells
13%
Childhood Acute Lymphoblastic Leukemia
13%
Pediatric Cancer
12%
Clinical Trials
12%
Minimal Residual Disease
12%
Leukemia Patients
11%
Adult Cancer
11%
Medulloblastoma
11%
Pediatric Cancer Patients
11%
BCP-ALL
11%
Testicular Germ Cell Tumor
11%
Systematic Meta-analysis
10%
L-asparaginase
10%
Methotrexate
10%
Stem Cells
10%
Europe
10%
Tumor Subtype
10%
Hazard Ratio
10%
Clinical Practice Guidelines
10%
Oncology
10%
Malignancy
10%
Tumor Research
10%
Healthcare Professionals
10%
Hematopoietic Stem Cell Transplantation
9%
Tumor Cells
9%
Patient-derived
9%
Central Nervous System Tumors
9%
Cancer Guidelines
9%
Diffuse Intrinsic Pontine Glioma
9%
Pediatric Tumors
9%
Clinical Practice
9%
Quality of Life
9%
Brain Tumor
9%
Clinical Outcomes
9%
Cisplatin
8%
Clinically Significant
8%
Germ Cells
8%
Hematopoietic Stem Cells
8%
Bone Marrow
8%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
8%
Tumor Organoids
8%
Risk Stratification
8%
Newly Diagnosed
8%
Melanoma
8%
Gene Expression
8%
Colorectal Cancer
8%
Liquid Biopsy
8%
Young Adult Cancer Survivors
8%
Cancer Types
8%
Preadolescent children
8%
Solid Tumors
8%
Glioma
8%
Copy number Variation
8%
Germ Cell Tumor
8%
International Society
7%
Glioblastoma
7%
Targeted Therapy
7%
Graft-versus-host Disease (GvHD)
7%
Patient-Reported Outcomes Measurement Information System (PROMIS)
7%
Hematological Malignancies
7%
Atypical Teratoid Rhabdoid Tumor (AT/RT)
7%
High-risk Neuroblastoma
7%
Survival Rate
7%
Medicine and Dentistry
Childhood Cancer
100%
Pediatrics
98%
Neoplasm
97%
Malignant Neoplasm
78%
Disease
50%
Acute Lymphoblastic Leukemia
48%
Adolescence
42%
Organoid
39%
Ganglioneuroblastoma
38%
Chemotherapy
34%
Wilms' Tumor
31%
Systematic Review
29%
Radiation Therapy
27%
Rhabdomyosarcoma
26%
Overall Survival
24%
Diagnosis
23%
Acute Myeloid Leukemia
21%
Pediatrics Patient
20%
Pediatric Cancer
19%
Soft Tissue Sarcoma
19%
Kidney Tumour
18%
Late Effect
18%
Oncology
17%
Leukemia
17%
Event Free Survival
16%
Cancer
15%
Ganglioglioma
15%
Cancer Therapy
15%
Pediatric Acute Myeloid Leukemia
14%
B Cell
14%
Biological Marker
14%
In Vitro
14%
Clinical Trial
14%
Cancer in Young Adults
14%
Quality of Life
13%
Immunotherapy
13%
Precursor
13%
T Cell
12%
Hematopoietic Cell
12%
Intracranial Tumor
12%
Melanoma
12%
Minimal Residual Disease
11%
Solid Malignant Neoplasm
11%
Recurrent Disease
11%
Cohort Analysis
11%
Stem Cell
10%
Germinoma
10%
Metastatic Carcinoma
10%
Surgery
10%
Hematopoietic Stem Cell Transplantation
9%
Central Nervous System Tumor
9%
Magnetic Resonance Imaging
9%
Prevalence
9%
Central Nervous System
9%
Survival Rate
8%
Gene Expression
8%
Medulloblastoma
8%
Meta-Analysis
8%
Risk Stratification
8%
Hazard Ratio
8%
Immunity
7%
Tumor Cell
7%
Cell Transplantation
7%
Breast Cancer
7%
Liquid Biopsy
7%
Targeted Therapy
7%
Adverse Event
6%
COVID-19
6%
microRNA
6%
Prognostic Factor
6%
Differentiated Thyroid Cancer
6%
Personalized Medicine
6%
Cancer Treatment
6%
Somatics
6%
Glioblastoma
6%
Randomized Controlled Trial
6%
Hematologic Malignancy
5%
Clustered Regularly Interspaced Short Palindromic Repeat
5%
Supportive Care
5%
Cisplatin
5%
Odds Ratio
5%
Xenograft
5%
High Risk Population
5%
Colorectal Carcinoma
5%
Germ Cell
5%
Pontine Glioma
5%
Cancer Research
5%
Infection
5%
Biopsy Technique
5%
RNA Sequence
5%
Disease Predisposition
5%
Fertility Preservation
5%
Primary Tumor
5%
Atypical Teratoid Rhabdoid Tumor
5%
Connective Tissue Cancer
5%
Immunohistochemistry
5%
Side Effect
5%